Skip to main content

Advertisement

Table 1 Patient characteristics

From: Radiotherapy may improve overall survival of patients with T3/T4 transitional cell carcinoma of the renal pelvis or ureter and delay bladder tumour relapse

  n Non-RT RT p value
Age (average)   68.5 ± 1.430 66.2 ± 1.208 0.074
   < 60 years 31 14(21.2%) 17(25.4%) 0.570
   ≥60 years 102 52(78.8%) 50(74.6%)  
Sex     
   Female 50 28(42.4%) 22(32.8%) 0.254
   Male 83 38(57.6%) 45(67.2%)  
Tumor location     
   Renal pelvis 42 26(39.4%) 16(23.9%) 0.054
   Ureter 91 40(60.6%) 51(76.1%)  
Tumor lesions     
   Solitary 117 61(92.4%) 56(83.6%) 0.117
   Multiple nodules 16 5(7.6%) 11(16.4%)  
Pathologic T stage     
   T1 21 12(18.2%) 9(13.4%) 0.083
   T2 60 30(45.5%) 30(44.8%)  
   T3 33 11(16.7%) 22(32.8%)  
   T4 19 13(19.7%) 6(9.0%)  
Synchronous LN     
   - 124 61(92.4%) 63(94.0%) 0.712
   + 9 5(7.6%) 4(6.0%)  
Resection modality     
   Local resection 22 17(25.8%) 5(7.5%) 0.004
   Nephroureterectomy 111 49(74.2%) 62(92.5%)  
Residual Disease     
   R0 108 53(80.3%) 55(82.1%) 0.816
   R1 11 5(7.6%) 6(9.0%)  
   R2 14 8(12.1%) 6(9.0%)  
Histological grade     
   I 6 5(7.6%) 1(1.5%) 0.195
   II 73 38(57.6%) 35(52.2%)  
   III 51 21(31.8%) 30(44.8%)  
   IV 3 2(3.0%) 1(1.5%)  
  1. RT: Radiation Therapy, LN: Lymph Node